Nurse Practitioner Program year 2025 Reported 2024–2025 Source: CMS Open Payments, 2026 publication

Bonnie Rosenberg

Nurse Practitioner San Antonio, TX Nurse Practitioner

NPI 1497589543 CMS profile 11609709

4410 Medical Dr Ste 320, San Antonio, TX 78229

Open in the dashboard

General payments

$7,676

221 records reported · program years 2024–2025

Research payments

$0

Paid to them · None reported · program years 2024–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Bonnie Rosenberg of San Antonio, TX is reported in the CMS Open Payments database as having received $7,676 across 221 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $7,484 213
2024 General $192 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bonnie Rosenberg
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Bonnie Rosenberg were reported at $7,484. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Bonnie Rosenberg Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $0 $135 $40–$426 $132
2022 $0 $152 $48–$470 $149
2023 $0 $166 $54–$529 $160
2024 $192 $173 $55–$556 $164
2025 $7,484 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2024–2025
  1. Medtronic, Inc. $1,320 10 payments
  2. Boston Scientific Corporation $1,175 10 payments
  3. Abbott Laboratories $821 11 payments
  4. AbbVie, Inc. $522 26 payments
  5. Celgene Corporation $378 27 payments
  6. Teva Pharmaceuticals USA, Inc. $326 10 payments
  7. Pfizer Inc. $287 16 payments
  8. LivaNova USA, Inc. $234 5 payments
  9. Lundbeck LLC $217 13 payments
  10. Merz Pharmaceuticals, LLC $216 6 payments
  11. Other $2,180 87 payments

Every payment, record by record

What the payments were for General payments · program years 2024–2025
  1. Food and Beverage $5,463 210 payments
  2. Travel and Lodging $2,213 11 payments
Products named General payments · program years 2024–2025
  1. PERCEPT PC BRAINSENSE $1,320 10 payments
  2. Vercise $1,164 9 payments
  3. INFINITY $767 9 payments
  4. ZEPOSIA $378 27 payments
  5. UBRELVY $357 18 payments
  6. QULIPTA $356 18 payments
  7. Austedo XR $326 10 payments
  8. ZAVZPRET $277 15 payments
  9. VNS THERAPY SENTIVA MODEL 1000 GENERATOR $234 5 payments
  10. Qutenza $210 6 payments
  11. Other $2,620 128 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

221 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record